English中文

Offstream
news


Bayer AG

Bayer and Johnson & Johnson announce that they have reached a $775 million agreement to settle approximately 25,000 outstanding litigation cases, which claim that their drug Xarelto caused severe and sometimes fatal bleeding episodes. Bayer and Johnson & Johnson had successfully defended the safety of the drug in all six prior cases that went to trial.

Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million

Sources:  The New York Times


Related